about
Children's Oncology Group's 2013 blueprint for research: radiation oncologyRectal dose-volume differences using proton radiotherapy and a rectal balloon or water alone for the treatment of prostate cancer.Patterns of chemotherapy-induced toxicities in younger children and adolescents with rhabdomyosarcoma: a report from the Children's Oncology Group Soft Tissue Sarcoma CommitteeCine-magnetic resonance imaging assessment of intrafraction motion for prostate cancer patients supine or prone with and without a rectal balloon.Virtual reality in surgical training.Radiotherapy for soft tissue sarcoma of the proximal lower extremityEvaluation of children with craniopharyngioma using carbon-11 methionine PET prior to proton therapyLong-term treatment outcomes for patients with synovial sarcoma: a 40-year experience at the University of Florida.Clinical and molecular features of papillary thyroid cancer in adolescents and young adultsProton therapy versus photon radiation therapy for the management of a recurrent desmoid tumor of the right flank: a case report.Imaging changes in very young children with brain tumors treated with proton therapy and chemotherapy.Agreement among RTOG sarcoma radiation oncologists in contouring suspicious peritumoral edema for preoperative radiation therapy of soft tissue sarcoma of the extremityLong-term clinical and functional outcomes after treatment for localized Ewing's tumor of the lower extremity.Squamous cell carcinoma of the external auditory canal: long-term clinical outcomes using surgery and external-beam radiotherapy.Spinal and paraspinal Ewing tumors.Erectile dysfunction after radiotherapy for prostate cancer.Ewing tumors of the head and neck.Long-term results following postoperative radiotherapy for soft tissue sarcomas of the extremity.Dendritic cell immunotherapy in soft tissue sarcoma.Late toxicity following craniospinal radiation for early-stage medulloblastoma.Increasing the number of clinical trials available to adolescents diagnosed with cancer.Local control in non-metastatic medulloblastoma.Proton therapy for the treatment of children with CNS malignancies.Response to sunitinib in combination with proton beam radiation in a patient with chondrosarcoma: a case report.Image guided radiation therapy (IGRT) technologies for radiation therapy localization and delivery.A treatment planning comparison of highly conformal radiation therapy for pediatric low-grade brainstem gliomas.Improving the therapeutic ratio by using proton therapy in patients with stage I or II seminoma.Long-term Outcomes Following Radiotherapy for Adolescent Patients With Nonmetastatic WHO Type III Nasopharyngeal Carcinoma.Long-term outcomes in breast cancer patients with ten or more positive axillary nodes treated with combined-modality therapy: the importance of radiation field selection.Analysis of dose at the site of second tumor formation after radiotherapy to the central nervous system.Radiation therapy for angiosarcoma: the 35-year University of Florida experience.Incidence and dosimetric parameters of pediatric brainstem toxicity following proton therapy.Adjuvant radiotherapy for pediatric and young adult nonrhabdomyosarcoma soft-tissue sarcoma.Does surgical closure technique affect early mammographic detection of tumor recurrence after breast-conserving therapy?Cutaneous squamous cell carcinoma metastatic to parotid-area lymph nodes.Impact of local management on long-term outcomes in Ewing tumors of the pelvis and sacral bones: the University of Florida experience.Function Preservation After Conservative Resection and Radiotherapy for Soft-tissue Sarcoma of the Distal Extremity: Utility and Application of the Toronto Extremity Salvage Score (TESS).Clinical outcomes following proton therapy for children with central nervous system tumors referred overseas.Early outcomes and patterns of failure following proton therapy for nonmetastatic intracranial nongerminomatous germ cell tumors.Proton therapy dose distribution comparison between Monte Carlo and a treatment planning system for pediatric patients with ependymoma.
P50
Q27023346-68016195-5376-4110-AE8D-04034E287299Q31134529-C10851E5-C523-4989-B5F9-0B371FFDF875Q33396263-902E9107-5CCF-41A0-A312-FC7ECFBF2884Q33499974-A2633D9B-9BE2-4FDB-83F1-173325123F23Q33796672-FB092AB3-9B80-46B5-A3DB-A4DA730E7AA5Q34215160-6A9FE487-A993-47B9-B802-C3AB8962B550Q34585628-9EF7C840-2F08-4330-8812-C12192983FC5Q34635293-155E2B1B-D68D-4ACD-9B9A-3AE8287460ECQ36293091-BD01C43D-45AF-428A-BC4E-14512FBCE00FQ36524125-C4BD2404-FD5F-47F3-9884-F4B7A9595BA3Q36612126-8D2C0509-FA1D-433C-8FEF-E9E7C287E3E5Q36823787-F142EA4A-7EF3-403F-A31F-5CB4F5758E8DQ36940251-881D649F-909C-4D21-AC77-0C9AF99D89B5Q37462032-1FA8B820-3EB1-4992-9B68-375961BBFF1DQ37562091-88BE0087-B8ED-4176-B36A-9F4930733C03Q37573342-A0959E47-4E24-4E14-AD85-15FFF5DCD907Q37617914-A87D8392-BA09-4373-8716-A1D824E9E5EDQ38007677-73CC83FA-062C-4101-A063-1195507C10A5Q38059515-5C65BE47-98C0-4288-9BEC-4327437CE60EQ38190624-49C24293-1B0D-44BD-8A03-2102030FB660Q38219433-20058D89-7B42-400F-AB64-8BE9D2B44A53Q38225901-0BB2733C-2953-4E03-845B-EDF0F1CA1A2FQ38233175-BE923DB3-8F22-41A4-A201-E682C9613587Q39252570-1D7E1B7A-E893-41C7-ADE6-CDEDDBF23821Q39420955-F3679D98-B959-4961-9AD1-9C661259A9C7Q43148723-5C906E2F-177B-4963-9EBC-37B71A93185AQ43789247-915F1833-07BB-4242-A872-F50E6A980B1FQ44183967-3E8658FB-C4AF-4BA1-90A5-2C3B454ECC8DQ44380735-B9D200C0-3198-4028-9390-8D0932218C4DQ44655416-1B2D3341-72ED-49A4-9B59-FE465FD6DC35Q44701323-F2C7073C-97AE-4C3D-AC43-377DA74EF22AQ44734006-3667A0E0-B37B-4C72-9D2A-D31D9AC10D6BQ44844748-8B38AFE9-2744-4396-8D3B-23EB16713AC1Q45233501-DC3CD331-BC0B-4C86-877E-AF87BCD574BDQ46730428-63F9C733-F238-4AA1-ABB9-C271785A7723Q46782577-51F96881-B016-4084-ACD2-D08860DE33F5Q48070549-5E0CAE27-0596-4CC3-A3FE-F03DF5E29206Q48092422-3F35E8EB-E467-4FFE-9E25-A1958F510149Q48143913-9AA93BCC-AAF1-4379-8919-93F946357527Q48408675-A9863B5C-861E-4AD5-966E-099CA04FC1A3
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Daniel Indelicato
@ast
Daniel Indelicato
@en
Daniel Indelicato
@es
Daniel Indelicato
@nl
Daniel Indelicato
@sl
type
label
Daniel Indelicato
@ast
Daniel Indelicato
@en
Daniel Indelicato
@es
Daniel Indelicato
@nl
Daniel Indelicato
@sl
altLabel
Danny
@en
prefLabel
Daniel Indelicato
@ast
Daniel Indelicato
@en
Daniel Indelicato
@es
Daniel Indelicato
@nl
Daniel Indelicato
@sl
P106
P21
P31
P3835
daniel-indelicato
P496
0000-0001-5765-1873